United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Aug 7, 2026 · Filed Aug 10, 2026

On Aug 7, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$531.38 for US$5.05M under a trading plan, leaving 324,443 shares. Filed Aug 10, 2026 (Form 4).

Sold
9,500 shares
Price
US$531.38 average (US$525.29 to US$540.32)
Value
US$5.05M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 7, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Aug 7, 2026Common StockSale357US$525.29333,586Indirect
Aug 7, 2026Common StockSale1,112US$526.15332,474Indirect
Aug 7, 2026Common StockSale411US$526.82332,063Indirect
Aug 7, 2026Common StockSale240US$527.72331,823Indirect
Aug 7, 2026Common StockSale709US$529.14331,114Indirect
Aug 7, 2026Common StockSale1,450US$530.32329,664Indirect
Aug 7, 2026Common StockSale2,781US$531.30326,883Indirect
Aug 7, 2026Common StockSale183US$532.01326,700Indirect
Aug 7, 2026Common StockSale160US$533.37326,540Indirect
Aug 7, 2026Common StockSale200US$534.27326,340Indirect
Aug 7, 2026Common StockSale160US$535.31326,180Indirect
Aug 7, 2026Common StockSale360US$536.99325,820Indirect
Aug 7, 2026Common StockSale625US$538.54325,195Indirect
Aug 7, 2026Common StockSale632US$539.14324,563Indirect
Aug 7, 2026Common StockSale120US$540.32324,443Indirect

Source

View original at SEC

Related